Factors associated with increased risk for dementia in individuals age 80 years or older with congestive heart failure

Journal of Cardiovascular Nursing

Volumn 29, Issue 1, 2014, Pages 82-90

  Hjelm, Carina ^a   Broström, Anders ^b,c   Dahl, Anna ^c,d   Johansson, Boo ^e   Fredrikson, Mats ^f   Strömberg, Anna ^a,b  

^a LINKÖPING UNIVERSITY   (Sweden)

^b LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^c JÖNKÖPING UNIVERSITY   (Sweden)

^d KAROLINSKA INSTITUTE   (Sweden)

^e UNIVERSITY OF GOTHENBURG   (Sweden)

^f Division of Occupational and EnvironmentalMedicine ^*  (Sweden)

Author keywords

Alzheimer's disease; Dementia; Heart failure; octogenarians; risk factors; vascular dementia

Indexed keywords

BIOLOGICAL MARKER; HOMOCYSTEINE;

ARTICLE; BLOOD; DEMENTIA; DEPRESSION; DIABETES MELLITUS; FEMALE; HEART FAILURE; HUMAN; HYPERTENSION; MALE; MULTIINFARCT DEMENTIA; PREVALENCE; VERY ELDERLY;

AGED, 80 AND OVER; BIOLOGICAL MARKERS; DEMENTIA; DEMENTIA, VASCULAR; DEPRESSION; DIABETES MELLITUS; FEMALE; HEART FAILURE; HOMOCYSTEINE; HUMANS; HYPERTENSION; MALE; PREVALENCE;

EID: 84890438373     PISSN: 08894655     EISSN: 15505049     Source Type: Journal    
DOI: 10.1097/JCN.0b013e318275543d     Document Type: Article

References (48)

1. Dickstein K, Cohen-Solal A, Filippatos G, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008. Eur J Heart Fail. 2008;10(10):933-989.
2. Plassman BL, Langa KM, Fisher GG, et al. Prevalence of dementia in the United States: the aging, demographics, and memory study. Neuroepidemiology. 2007;29(1-2):125-132.
3. Qiu C, De Ronchi D, Fratiglioni L. The epidemiology of the dementias: an update. Curr Opin Psychiatry. 2007; 20(4):380-385.
4. Rosemberg GA, Haaland RY. Cardiogenic dementia. Lancet. 1981;2(8256):1171.
5. Heckman GA, Patterson CJ, Demers C, St Onge J, Turpie ID, McKelvie RS. Heart failure and cognitive impairment: challenges and opportunities. Clin Interv Aging. 2007;2(2):209-218.
6. Pressler SJ, Subramanian U, KarekenD, et al. Cognitive deficits in chronic heart failure. Nurs Res. 2010;59(2):127-139.
7. Pressler SJ, Subramanian U, Kareken D, et al. Cognitive deficits and health-related quality of life in chronic heart failure. J Cardiovasc Nurs. 2010;25(3):189-198.
8. Hjelm C, Dahl A, Brostrom A, Martensson J, Johansson B, Stromberg A. The influence of heart failure on longitudinal changes in cognition among individuals 80 years of age and older. J Clin Nurs. 2011;21(7-8):994-1003.
9. Pressler SJ. Cognitive functioning and chronic heart failure: a review of the literature (2002-July 2007). J Cardiovasc Nurs. 2008;23(3):239-249.
10. Woo MA, Macey PM, Keens PT, et al. Functional abnormalities in brain areas that mediate autonomic nervous system control in advanced heart failure. J Card Fail. 2005; 11(6):437-446.
11. Kumar R, Nguyen HD, Ogren JA, et al. Global and regional putamen volume loss in patients with heart failure. Eur J Heart Fail. 2011;13(6):651-655.
12. James BD, Bennett DA, Boyle PA, Leurgans S, Schneider JA. Dementia from Alzheimer disease and mixed pathologies in the oldest old. JAMA. 2012;307(17):1798-1800.
13. Savva GM, Wharton SB, Ince PG, Forster G, Matthews FE, Brayne C. Age, neuropathology, and dementia. N Engl J Med. 2009;360(22):2302-2309.
14. Riegel B, Dickson VV, Cameron J, et al. Symptom recognition in elders with heart failure. J Nurs Scholarsh. 2010;42(1):92-100.
15. Debette S, Bauters C, Leys D, Lamblin N, Pasquier F, de Groote P. Prevalence and determinants of cognitive impairment in chronic heart failure patients. Congest Heart Fail. 2007;13(4):205-208.
16. McClearn GE, Johansson B, Berg S, et al. Substantial genetic influence on cognitive abilities in twins 80 or more years old. Science. 1997;276(5318):1560-1563.
17. Nilsson SE, Johansson B, Berg S, Karlsson D, McClearn GE. A comparison of diagnosis capture from medical records, self-reports, and drug registrations: a study in individuals 80 years and older. Aging Clin Exp Res. 2002;14(3): 178-184.
18. Nilsson SE, Takkinen S, Tryding N, et al. Association of biochemical values with morbidity in the elderly: a populationbased Swedish study of persons aged 82 or more years. Scand J Clin Lab Invest. 2003;63(7-8):457-466.
19. Shah RV, Givertz MM. Managing acute renal failure in patients with acute decompensated heart failure: the cardiorenal syndrome. Curr Heart Fail Rep. 2009;6(3):176-181.
20. Cacciapuoti F. Hyper-homocysteinemia: a novel risk factor or a powerful marker for cardiovascular diseases? Pathogenetic and therapeutical uncertainties. J Thromb Thrombolysis. 2011;32(1):82-88.
21. Qiu C, Xu W, Winblad B, Fratiglioni L. Vascular risk profiles for dementia and Alzheimers disease in very old people: a population-based longitudinal study. J Alzheimers Dis. 2010;20(1):293-300.
22. Bohm M, Voors AA, Ketelslegers JM, et al. Biomarkers: optimizing treatment guidance in heart failure. Clin Res Cardiol. 2011;100(11):973-981.
23. CederlofR, Lorich U. The Swedish Twin Registry. Progr Clin Biol Res. 1978;24(Pt B):189-195.
24. ICD-10. International Statistical Classification of Diseases and Health Problems. Geneva, Switzerland: World Health Organization; 1992.
25. Pedersen NL, Gatz M, Berg S, Johansson B. How heritable is Alzheimers disease late in life? Findings from Swedish twins. Ann Neurol. 2004;55(2):180-185.
26. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 3rd rev ed. Washington, DC: American Psychiatric Association; 1987.
27. McKhann G, Drachman D, FolsteinM, KatzmanR, PriceD, Stadlan EM. Clinical diagnosis of Alzheimers disease: report of the NINCDS-ADRDAWork Group under the auspices of Department of Health and Human Services Task Force on Alzheimers Disease. Neurology. 1984;34(7):939-944.
28. Roman GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies: report of the NINDS-AIREN International Workshop. Neurology. 1993;43(2):250-260.
29. McDowell INC, ed. Measuring Health: A Guide to Rating Scales and Questionnaires. 2nd ed. New York: NY: Oxford University Press; 1996.
30. FolsteinMF, Folstein SE, McHugh PR. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189-198.
31. Crum RM, Anthony JC, Bassett SS, Folstein MF. Populationbased norms for the Mini-Mental State Examination by age and educational level. JAMA. 1993;269(18):2386-2391.
32. Goodglass H, Kaplan E. The Assessment of Aphasia and RelatedDisorders. Philadelphia, PA: Lea & Febiger; 1983.
33. Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics. 1986;42(1): 121-130.
34. Camus V, Kraehenbuhl H, Preisig M, Bula CJ, Waeber G. Geriatric depression and vascular diseases: what are the links? J Affect Disord. 2004;81(1):1-16.
35. Jorm AF. History of depression as a risk factor for dementia: an updated review. Aust N Z J Psychiatry. 2001;35(6): 776-781.
36. Molander L, Gustafson Y, Lovheim H. Low blood pressure is associated with cognitive impairment in very old people. Dement Geriatr Cogn Disord. 2010;29(4):335-341.
37. Nilsson SE, Read S, Berg S, Johansson B, Melander A, Lindblad U. Low systolic blood pressure is associated with impaired cognitive function in the oldest old: longitudinal observations in a population-based sample 80 years and older. Aging Clin Exp Res. 2007;19(1):41-47.
38. Thorvaldsson V, Skoog I, Hofer SM, et al. Nonlinear blood pressure effects on cognition in old age: Separating between-person and within-person associations. Psychol Aging. 2012;27(2):375-383.
39. Ruitenberg A, den Heijer T, Bakker SL, et al. Cerebral hypoperfusion and clinical onset of dementia: the Rotterdam Study. Ann Neurol. 2005;57(6):789-794.
40. Qiu C,Winblad B, Fratiglioni L. The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol. 2005;4(8):487-499.
41. Herrmann W, Herrmann M, Joseph J, Tyagi SC. Homocysteine, brain natriuretic peptide and chronic heart failure: a critical review. Clin Chem Lab Med. 2007;45(12):1633-1644.
42. Seshadri S. Elevated plasma homocysteine levels: risk factor or risk marker for the development of dementia and Alzheimers disease? J Alzheimers Dis. 2006;9(4):393-398.
43. Ravaglia G, Forti P, Maioli F, et al. Homocysteine and folate as risk factors for dementia and Alzheimer disease. Am J Clin Nutr. 2005;82(3):636-643.
44. Awad N, Gagnon M, Messier C. The relationship between impaired glucose tolerance, type 2 diabetes, and cognitive function. J Clin Exp Neuropsychol. 2004;26(8):1044-1080.
45. Cukierman T, Gerstein HC, Williamson JD. Cognitive decline and dementia in diabetesVsystematic overview of prospective observational studies. Diabetologia. 2005;48(12): 2460-2469.
46. Hassing LB, Johansson B, Nilsson SE, et al. Diabetes mellitus is a risk factor for vascular dementia, but not for Alzheimers disease: a population-based study of the oldest old. Int Psychogeriatr. 2002;14(3):239-248.
47. Dickson VV, Buck H, Riegel B. A qualitative metaanalysis of heart failure self-care practices among individuals with multiple comorbid conditions. J Card Fail. 2011;17(5): 413-419.
48. Dahl A, Berg S, Nilsson SE. Identification of dementia in epidemiological research: a study on the usefulness of various data sources. Aging Clin Exp Res. 2007;19(5): 381-389.